Back to Search
GIUSEPPE CONDEMI, M.D., PH.D.
M.D., PH.D.
Medical Oncology Physician
NPI: 1083660781IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25MA07282200(NJ)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1998
Research & Publications (4)
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
PMID 18719941·J Cancer Res Clin Oncol·2009
2-rct
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.
PMID 18493232·Br J Cancer·2008
3-trial
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
PMID 17298853·Lung Cancer·2007
3-trial
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
PMID 16020974·Oncology·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 215 E 95TH ST FRNT 2
NEW YORK, NY 10128 - Phone
- (718) 732-4049
Quick Facts
- NPI
- 1083660781
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 28
- Publications
- 4
Are you this provider?
Claim Your Profile